{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:59:02Z","timestamp":1792853942277,"version":"4.5.0"},"reference-count":51,"publisher":"Royal College of General Practitioners","issue":"708","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Gen Pract"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Given the prevalence of long-term benzodiazepine (BZD) prescribing, increased monitoring through the implementation of prescription monitoring programmes (PMPs) may be the necessary impetus to promote BZD deprescribing. Despite evidence promoting the importance of patient-centred care, GPs have not been sufficiently supported to implement these principles through current deprescribing practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To investigate patients\u2019 perception of their prescriber\u2019s influence on ceasing BZD use, including their willingness to take their advice, and to understand how a patient\u2019s stage of change influences the barriers and facilitators they perceive to discontinuing BZDs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and setting<\/jats:title><jats:p>An online survey and qualitative interviews with 22 long-term users of BZD (\u22656 months), aged 18\u201369 years, recruited from the general population in Victoria, Australia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Two groups of users of BZD participated, one in the process of reducing their BZD and one not reducing, and were categorised according to their stage of change. Data underwent thematic analysis to identify barriers and facilitators to reducing BZDs both at the patient level and the prescriber level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>BZD patients\u2019 perceptions of the prescriber influence were characterised by prescribing behaviours, treatment approach, and attitude. Barriers and facilitators to reducing their BZD were mapped against their stage of change. Irrespective of their stage of change, participants reported they would be willing to try reducing their BZD if they trusted their prescriber.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study illustrates that, with a few key strategies at each step of the deprescribing conversation, GPs are well positioned to tackle the issue of long-term BZD use in a manner that is patient centred.<\/jats:p><\/jats:sec>","DOI":"10.3399\/bjgp.2020.1062","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T13:45:56Z","timestamp":1620135956000},"page":"e517-e527","source":"Crossref","is-referenced-by-count":20,"title":["Role of the prescriber in supporting patients to discontinue benzodiazepines: a qualitative study"],"prefix":"10.3399","volume":"71","author":[{"given":"Erin","family":"Oldenhof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Anderson-Wurf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra K","family":"Staiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1987","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"2022062908501982000_71.708.e517.1","unstructured":"National Institute for Health and Care Excellence (2011) Generalised anxiety disorder and panic disorder in adults: management CG113 (NICE, London) www.nice.org.uk\/guidance\/cg113 (accessed 6 May 2021)."},{"key":"2022062908501982000_71.708.e517.2","unstructured":"Royal Australian College of General Practitioners (2015) Prescribing drugs of dependence in general practice, part B \u2014 benzodiazepines (RACGP, Melbourne) https:\/\/www.racgp.org.au\/getattachment\/1beeb924-cf7b-4de4-911e-f7dda3e3f6e9\/Part-B.aspx (accessed 6 May 2021)."},{"key":"2022062908501982000_71.708.e517.3","unstructured":"American Psychiatric Association (2009) Practice guideline for the treatment of patients with panic disorder (APA, Washington, DC) https:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/panicdisorder.pdf (accessed 6 May 2021)."},{"issue":"4","key":"2022062908501982000_71.708.e517.4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","article-title":"Benzodiazepines and z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research","volume":"17","author":"Brandt","year":"2017","journal-title":"Drugs R D"},{"issue":"1","key":"2022062908501982000_71.708.e517.5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nurpra.2020.08.004","article-title":"Reconsidering benzodiazepines and z-drug prescriptions: responsible prescribing and deprescribing","volume":"17","author":"McGee","year":"2021","journal-title":"J Nurse Pract"},{"key":"2022062908501982000_71.708.e517.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-000850"},{"issue":"7","key":"2022062908501982000_71.708.e517.7","first-page":"2121","article-title":"Addiction: part 1. benzodiazepines \u2014 side effects, abuse risks and alternatives","volume":"61","author":"Longo","year":"2000","journal-title":"Am Fam Physician"},{"key":"2022062908501982000_71.708.e517.8","unstructured":"Ashton CH (2002) Benzodiazepines: how they work & how to withdraw (Newcastle University, Newcastle)."},{"key":"2022062908501982000_71.708.e517.9","doi-asserted-by":"crossref","unstructured":"Davies J Rae TC Montagu L (2017) Long-term benzodiazepine and Z-drugs use in England: a survey of general practice [corrected]. Br J Gen Pract, DOI: https:\/\/doi.org\/10.3399\/bjgp17X691865.","DOI":"10.3399\/bjgp17X691865"},{"issue":"2","key":"2022062908501982000_71.708.e517.10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"2022062908501982000_71.708.e517.11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.psychres.2017.09.059","article-title":"Prescribing practices in Southeastern Europe: focus on benzodiazepine prescription at discharge from nine university psychiatric hospitals","volume":"258","author":"Maric","year":"2017","journal-title":"Psychiatry Res"},{"key":"2022062908501982000_71.708.e517.12","unstructured":"Liew D Joules E Booth J (2017) Evidence to inform the inclusion of Schedule 4 prescription medications on a real-time prescription monitoring system (Austin Health, Melbourne) https:\/\/ahro.austin.org.au\/austinjspui\/handle\/1\/16770 (accessed 6 May 2021)."},{"key":"2022062908501982000_71.708.e517.13","unstructured":"Office for National Statistics (2019) Deaths related to drug poisoning in England and Wales: 2018 registrations. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/bulletins\/deathsrelatedtodrugpoisoninginenglandandwales\/2018registrations (accessed 6 May 2021)."},{"key":"2022062908501982000_71.708.e517.14","unstructured":"(2021) NIH: National Institute on Drug Abuse. Overdose death rates, https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates (accessed 6 May 2021)."},{"issue":"12","key":"2022062908501982000_71.708.e517.15","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.3390\/jcm8122143","article-title":"Beyond prescriptions monitoring programs: the importance of having the conversation about benzodiazepine use","volume":"8","author":"Oldenhof","year":"2019","journal-title":"J Clin Med"},{"key":"2022062908501982000_71.708.e517.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2011.01245.x"},{"issue":"11","key":"2022062908501982000_71.708.e517.17","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/pm\/pnw019","article-title":"Clinical styles and practice policies: Influence on communication with patients regarding worrisome prescription drug monitoring program data","volume":"17","author":"Hildebran","year":"2016","journal-title":"Pain Med"},{"issue":"2","key":"2022062908501982000_71.708.e517.18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/10826084.2018.1491052","article-title":"Perceived unintended consequences of prescription drug monitoring programs","volume":"54","author":"Yuanhong Lai","year":"2019","journal-title":"Subst Use Misuse"},{"key":"2022062908501982000_71.708.e517.19","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2015.055"},{"key":"2022062908501982000_71.708.e517.20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-14-1"},{"key":"2022062908501982000_71.708.e517.21","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-019-0965-0"},{"issue":"1","key":"2022062908501982000_71.708.e517.22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12875-018-0885-4","article-title":"Attitudes and behaviour towards psychotropic drug prescribing in Swedish primary care: a questionnaire study","volume":"20","author":"Svensson","year":"2019","journal-title":"BMC Fam Pract"},{"key":"2022062908501982000_71.708.e517.23","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-006-0021-3"},{"key":"2022062908501982000_71.708.e517.24","doi-asserted-by":"publisher","DOI":"10.1080\/13607863.2015.1015961"},{"key":"2022062908501982000_71.708.e517.25","doi-asserted-by":"crossref","unstructured":"Lasserre A Youn\u00e8s N Blanchon T (2010) Psychotropic drug use among older people in general practice: discrepancies between opinion and practice. Br J Gen Pract, DOI: https:\/\/doi.org\/10.3399\/bjgp10X483922.","DOI":"10.3399\/bjgp10X483922"},{"key":"2022062908501982000_71.708.e517.26","doi-asserted-by":"crossref","first-page":"e5535","DOI":"10.7717\/peerj.5535","article-title":"Patient-centered care interventions to reduce the inappropriate prescription and use of benzodiazepines and z-drugs: a systematic review","volume":"6","author":"Mokhar","year":"2018","journal-title":"PeerJ"},{"key":"2022062908501982000_71.708.e517.27","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12386"},{"issue":"1","key":"2022062908501982000_71.708.e517.28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40271-016-0182-z","article-title":"A systematic review and meta-synthesis of patients\u2019 experiences and perceptions of seeking and using benzodiazepines and z-drugs: towards safer prescribing","volume":"10","author":"Sirdifield","year":"2017","journal-title":"Patient"},{"key":"2022062908501982000_71.708.e517.29","doi-asserted-by":"crossref","unstructured":"Mugunthan K McGuire T Glasziou P (2011) Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis. Br J Gen Pract, DOI: https:\/\/doi.org\/10.3399\/bjgp11X593857.","DOI":"10.3399\/bjgp11X593857"},{"issue":"2","key":"2022062908501982000_71.708.e517.30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm7020020","article-title":"Benzodiazepines II: waking up on sedatives: providing optimal care when inheriting benzodiazepine prescriptions in transfer patients","volume":"7","author":"Guina","year":"2018","journal-title":"J Clin Med"},{"key":"2022062908501982000_71.708.e517.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-015959"},{"key":"2022062908501982000_71.708.e517.32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004148.pub4"},{"key":"2022062908501982000_71.708.e517.33","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agt170"},{"key":"2022062908501982000_71.708.e517.34","unstructured":"Prochaska JO Redding CA Evers KE (2008) The Transtheoretical Model and Stage of Change. in Health behavior and health education: theory, research, and practice, eds Glanz K Rimer BK Viswanath K (John Wiley & Sons, San Francisco, CA), 97\u2013117."},{"key":"2022062908501982000_71.708.e517.35","doi-asserted-by":"publisher","DOI":"10.1177\/1049732316665344"},{"key":"2022062908501982000_71.708.e517.36","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"2022062908501982000_71.708.e517.37","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092"},{"key":"2022062908501982000_71.708.e517.38","unstructured":"Ware JE Kosinski M Dewey JE Gandek B (2001) How to score and interpret single-item health status measures : a manual for users of the of the SF-8 health survey (QualityMetric, Inc. Boston, MA)."},{"issue":"2","key":"2022062908501982000_71.708.e517.39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1360-0443.2000.95224511.x","article-title":"The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study","volume":"92","author":"De las Cuevas","year":"2000","journal-title":"Addiction"},{"key":"2022062908501982000_71.708.e517.40","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2022062908501982000_71.708.e517.41","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"issue":"6","key":"2022062908501982000_71.708.e517.42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/16066359.2011.569102","article-title":"Predictors of response to brief intervention in general practice against long-term benzodiazepine use","volume":"19","author":"Heather","year":"2011","journal-title":"Addict Res Theory"},{"key":"2022062908501982000_71.708.e517.43","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-013-0106-8"},{"key":"2022062908501982000_71.708.e517.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2005.07.016"},{"issue":"8","key":"2022062908501982000_71.708.e517.45","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1080\/01634372.2014.901470","article-title":"Perceptions of benzodiazepine dependence among age 65 and older","volume":"57","author":"Canham","year":"2014","journal-title":"J Gerontol Soc Work"},{"issue":"4","key":"2022062908501982000_71.708.e517.46","first-page":"137","article-title":"Percepciones y experiencias de usuarios de benzodiazepinas en la atenci\u00f3n primaria de salud en Cuba. [Perceptions and experiences of benzodiazepine users in primary health care in Cuba]","volume":"28","author":"Fegadolli","year":"2019","journal-title":"Sa\u00fade Soc"},{"issue":"1","key":"2022062908501982000_71.708.e517.47","first-page":"23","article-title":"Evaluation of the medical orientation for the benzodiazepine side effects","volume":"26","author":"Auchewski","year":"2004","journal-title":"Braz J Psychiatry"},{"key":"2022062908501982000_71.708.e517.48","doi-asserted-by":"publisher","DOI":"10.3399\/bjgpopen18X101626"},{"issue":"9","key":"2022062908501982000_71.708.e517.49","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.addbeh.2008.02.003","article-title":"Social-cognitive predictors of intended and actual benzodiazepine cessation among chronic benzodiazepine users","volume":"33","author":"Ten Wolde","year":"2008","journal-title":"Addict Behav"},{"key":"2022062908501982000_71.708.e517.50","unstructured":"Royal Australian & New Zealand College of Psychiatrists (2015) Guidance for the use of benzodiazepines in psychiatric practice (RANZCP, Melbourne) https:\/\/www.ranzcp.org\/files\/resources\/college_statements\/practice_guidelines\/ppg5-use-of-benzodiazepines.aspx (accessed 6 May 2021)."},{"key":"2022062908501982000_71.708.e517.51","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp19X704705"}],"container-title":["British Journal of General Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3399\/BJGP.2020.1062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T15:53:57Z","timestamp":1656518037000},"score":1,"resource":{"primary":{"URL":"http:\/\/bjgp.org\/lookup\/doi\/10.3399\/BJGP.2020.1062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":51,"journal-issue":{"issue":"708","published-online":{"date-parts":[[2021,6,24]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.3399\/BJGP.2020.1062"],"URL":"https:\/\/doi.org\/10.3399\/bjgp.2020.1062","relation":{},"ISSN":["0960-1643","1478-5242"],"issn-type":[{"value":"0960-1643","type":"print"},{"value":"1478-5242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]}}}